These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36148653)

  • 1. Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function.
    Bigalke JA; Shan Z; Carter JR
    Hypertension; 2022 Dec; 79(12):2643-2655. PubMed ID: 36148653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin Receptor Antagonists and Insomnia.
    Wu X; Xue T; Chen Z; Wang Z; Chen G
    Curr Psychiatry Rep; 2022 Oct; 24(10):509-521. PubMed ID: 35972717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
    Roecker AJ; Cox CD; Coleman PJ
    J Med Chem; 2016 Jan; 59(2):504-30. PubMed ID: 26317591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.
    Carpi M; Palagini L; Fernandes M; Calvello C; Geoffroy PA; Miniati M; Pini S; Gemignani A; Mercuri NB; Liguori C
    Neuropharmacology; 2024 Mar; 245():109815. PubMed ID: 38114045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.
    Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes and Consequences of Chronic Sleep Deficiency and the Role of Orexin.
    Mullington JM; Cunningham TJ; Haack M; Yang H
    Front Neurol Neurosci; 2021; 45():128-138. PubMed ID: 34052807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.
    Shariq AS; Rosenblat JD; Alageel A; Mansur RB; Rong C; Ho RC; Ragguett RM; Pan Z; Brietzke E; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():1-7. PubMed ID: 30576764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.
    Kumar A; Chanana P; Choudhary S
    Pharmacol Rep; 2016 Apr; 68(2):231-42. PubMed ID: 26922522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the Mysteries of Sleep.
    Yanagisawa M
    Keio J Med; 2019; 68(1):27. PubMed ID: 30905886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.
    Mahoney CE; Mochizuki T; Scammell TE
    Sleep; 2020 Jun; 43(6):. PubMed ID: 31830270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin antagonists for insomnia.
    Young J; Lee E; Lindblad AJ; Falk J
    Can Fam Physician; 2024 Mar; 70(3):183-184. PubMed ID: 38499379
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?
    Berteotti C; Calvello C; Liguori C
    Epilepsia; 2023 Aug; 64(8):1991-2005. PubMed ID: 37212716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment.
    Palagini L; Geoffroy PA; Balestrieri M; Miniati M; Biggio G; Liguori C; Menicucci D; Ferini-Strambi L; Nobili L; Riemann D; Gemignani A
    J Sleep Res; 2023 Aug; 32(4):e13825. PubMed ID: 36786121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease.
    Kron JOJ; Keenan RJ; Hoyer D; Jacobson LH
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():359-386. PubMed ID: 37708433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin OX
    Jacobson LH; Chen S; Mir S; Hoyer D
    Curr Top Behav Neurosci; 2017; 33():105-136. PubMed ID: 27909987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orexin story and orexin receptor antagonists for the treatment of insomnia.
    Muehlan C; Roch C; Vaillant C; Dingemanse J
    J Sleep Res; 2023 Dec; 32(6):e13902. PubMed ID: 37086045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of suvorexant.
    Stahl SM
    CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia.
    Ziemichód W; Grabowska K; Kurowska A; Biała G
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.